Oregon Compounding Centers, Inc. dba Creative Comp Recall: CEFTAZIDIME, 2.25mg/0.1mL, Inje
Oregon Compounding Centers, Inc. dba Creative Comp Recall: CEFTAZIDIME, 2.25mg/0.1mL, Inje is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Oregon Compounding Centers, Inc. dba Creative Compounds; Product: CEFTAZIDIME, 2.25mg/0.1mL, Injectable, 0.2 mL plastic syringe, RX, Creative Compo
| Recalling firm | Oregon Compounding Centers, Inc. dba Creative Compounds |
|---|---|
| Product | CEFTAZIDIME, 2.25mg/0.1mL, Injectable, 0.2 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070 |
| Reason for recall | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Oregon, Washington |
| Recall initiated | 20141006 |
| Recall number | D-0180-2015 |
| Category | drug |
| State | OR |
| Country | United States |
$29/mo
Try RecallGuard →